FES Therapy + Task-Specific Training for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether the timing of combining functional electrical stimulation therapy (which uses electrical currents to stimulate nerves) with task-specific training can improve recovery after a spinal cord injury. Participants will be divided into two groups: one will start the treatment 3 to 6 months after their injury, and the other will begin 6 to 9 months post-injury. The trial aims to determine which timing leads to better functional and neurological recovery. It seeks individuals who have experienced a motor incomplete spinal cord injury affecting their neck within the last 3 months. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance recovery strategies for spinal cord injuries.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this therapy is safe for spinal cord injury patients?
Research has shown that functional electrical stimulation (FES) therapy combined with task-specific training (TST) is generally safe and well-tolerated. One study found that using automated FES to assist with walking was safe and well-received by participants. This suggests that combining FES and TST does not lead to serious side effects.
FES therapy has also been used successfully in individuals with paralysis from spinal cord injuries or strokes, supporting its safety. However, evidence on its effectiveness in improving arm and hand function is mixed, indicating a need for further research.
In summary, while FES with TST appears safe, its effectiveness can vary, and additional studies are necessary for a clearer understanding.12345Why are researchers excited about this trial?
Researchers are excited about FEST+TST for spinal cord injury because it combines two innovative approaches: Functional Electrical Stimulation Therapy (FES) and Task-Specific Training (TST). Unlike traditional rehabilitation methods, which might focus on general strength and conditioning, this treatment specifically targets nerve and muscle activation through electrical stimulation while simultaneously training patients to perform everyday tasks. This dual-action approach aims to enhance neural recovery and improve motor function more effectively and rapidly than current therapies. By potentially facilitating more targeted and faster rehabilitation, FEST+TST represents a promising advancement in spinal cord injury recovery.
What evidence suggests that this trial's treatments could be effective for spinal cord injury?
Research has shown that functional electrical stimulation (FES) combined with task-specific training (TST) can improve movement and function in people with spinal cord injuries. In this trial, participants will receive either Early FEST + TST or Delayed FEST + TST. Studies indicate that FES can assist those with paralysis due to spinal cord injuries or strokes. Moderate evidence suggests that FES can enhance upper limb function, although some study results vary. Together, FES and TST can positively impact the system controlling muscle movements. These findings suggest that this combined therapy could effectively aid recovery after a spinal cord injury.12346
Who Is on the Research Team?
Julio Furlan, MD, PhD
Principal Investigator
KITE, Toronto Rehab-University Health Network
Are You a Good Fit for This Trial?
This trial is for individuals in the early stages (less than 3 months) after a traumatic spinal cord injury at the neck level that still allows for some movement. It's not suitable for those with other medical conditions affecting treatment, neurological diseases, severe mental illness, learning disabilities, recent substance abuse, MRI contraindications, or sensory deficits impacting tests.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Early Treatment
Participants receive FEST+TST at 3 to 6 months from SCI onset
Delayed Treatment
Participants receive FEST+TST at 6 to 9 months from SCI onset
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- FEST+TST
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor